Articles
-
Nov 28, 2024 |
spotlightnsp.co.za | Ufrieda Ho |Amy Green |Elri Voigt |Laura Owings
South Africa’s HIV testing programme has been a huge success over the last decade, largely due to the use of rapid tests. (File photo: Unicef) Comment & Analysis28th November 2024 | Salim S.
-
Nov 12, 2024 |
spotlightnsp.co.za | Ufrieda Ho |Amy Green |Warren Potter |Jesse Copelyn
Researchers around the world are working hard to find a viable cure for the roughly 40 million people on the planet living with HIV. (Photo: This Is Engineering/Pexels) News & Features12th November 2024 | Elri Voigt Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus.
-
Aug 30, 2024 |
spotlightnsp.co.za | Luvuyo Mehlwana |Amy Green |Biénne Huisman |Laura Gonzalez |Laura González
South Africa has some of the highest TB and DR-TB incidence rates in the world. (Photo: Canva rework by Spotlight) Comment & Analysis30th August 2024 | Fatima Hassan and Leena Menghaney A Competition Commission probe recently resulted in a patent on an important tuberculosis medicine being dropped in South Africa.
-
Aug 21, 2024 |
spotlightnsp.co.za | Biénne Huisman |Amy Green |Aneesa Adams |Jesse Copelyn
Sister Sandra Bryant blows bubbles inside her clinic room at Chinn's Corner Pharmacy in Cape Town. (Photo: Biénne Huisman/Spotlight) News & Features21st August 2024 | Biénne Huisman Sister Sandra Bryant runs her clinic in a lilac painted room, where glitter cream and a disco ball does not seem out of place next to scissors, syringes, and needles.
-
Jul 1, 2024 |
spotlightnsp.co.za | Biénne Huisman |Amy Green |Khanyisa Mapipa |Salomé Meyer
Lenacapavir is in a relatively new class of antiretroviral medicines which interferes with the protein shell that protects HIV’s genetic material and the enzymes it needs for viral replication. (Photo: Gerd Altmann/Pixabay) News & Features1st July 2024 | Thabo Molelekwa and Marcus Low An HIV prevention injection that provides six months of protection per shot has been shown to be highly effective in a pivotal trial largely conducted in South Africa.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →